Top Pick Recombinant Ebov (subtype Bundibugyo, Strain Uganda 2007) Vp24 Protein (his Tag) For A Limited Time [6c2o0TDN]

High-Quality Recombinant EBOV VP24 Protein

This product offers a highly purified recombinant Ebola virus (EBOV) VP24 protein, specifically from the Bundibugyo subtype and the Uganda 2007 strain. This protein is produced through a robust expression system in E. coli, ensuring a high level of consistency and purity. The VP24 protein is conjugated with a His tag, facilitating easier purification and handling. This recombinant protein is an invaluable tool for researchers studying the Ebola virus, its replication cycle, and potential vaccine development.

• High purity > 90% as determined by reducing SDS-PAGE
• Conjugated with a His tag for easy purification
• Produced in E. coli for reliable expression

Product Specifications and Benefits

Our recombinant EBOV VP24 protein is provided in a lyophilized form, ensuring stability and ease of use. The protein is formulated in a buffer of 50 mM Tris, 500 mM NaCl, pH 8.0, with the addition of 5% - 8% trehalose, mannitol, and 0.01% Tween 80 as protectants. This formulation allows for long-term storage at -20 to -80°C, with reconstituted protein solutions stable at 4-8°C for up to 2-7 days. The protein's calculated molecular weight is 28.5 kDa, making it suitable for various biochemical applications.

• Lyophilized format for stability and convenience
• Storage at -20 to -80°C for up to 12 months
• Reconstituted protein solutions stable at 4-8°C for 2-7 days

Applications and Research Potential

The recombinant EBOV VP24 protein is an essential tool for researchers investigating the Ebola virus. It can be used in various applications, including virus replication studies, vaccine development, and diagnostic assays. The protein's high purity and specific sequence make it ideal for these research purposes. Additionally, the availability of the VP24 protein from different Ebola virus strains allows for a broader range of research possibilities.

• Useful for virus replication studies and vaccine development
• Contributes to the understanding of the Ebola virus lifecycle
• Enables the creation of diagnostic assays and potential therapeutic strategies